Empowering physicians, powering hearts

Crafting futures with every heartbeat

The WiSE CRT System is designed to overcome the limitations of conventional CRT and is the only leadless left ventricular endocardial pacing (LVEP) device.

Side view

Anchor

Retains Electrode during endothelization

Electrode

Converts ultrasonic energy into electrical pulse

Exterior

Polyester jacket for rapid endothelization

Device body

9.3 mm body length, 0.05 cc volume

Cathode

Maps thresholds pre-anchoring, delivers pacing pulse when anchored

Top view

2.8 mm diameter

Leadless

Ultra-compact leadless device removes constraints of lead-based pacing systems

Versatile

Open platform coordinates therapy
with a range of existing pacing devices

LV Endocardial

More physiologic approach via left ventricular endocardial pacing (LVEP) for CRT

Our Values

We prioritize the personal and professional growth of our team members and empower them to create the future of cardiac rhythm management.

Patients First

We place the needs of patients first in everything we do.

Positivity

We maintain a positive mindset that fosters trust, teamwork, and success.

Leadership

We believe leadership is an attitude, not just a role—everyone can contribute.

Expression

We encourage constructive debate and strive for continuous improvement.

News

JAMA WiSE CRT System

EBR's pivotal SOLVE-CRT Study published in JAMA Cardiology

JAMA Cardiology publishes EBR’s pivotal SOLVE-CRT study

ASX Quarterly Health Wrap: Who is making progress for FDA approval?

Australian Business Review article of EBR Systems progress in 2024

Person holding plastic heart

February 6, 2024

How big-hearted EBR Systems is pacing a multi-billion dollar cardiac market

EBR Systems pioneered the WiSE Cardiac Resynchronization Therapy (CRT) system tech, the size of a grain of rice.